Integrative Oncology: Scientific Research in Support of Patients: Useful, Possible, Valid

Abstract

The search for new anticancer drugs in the last years has shown its limits: no new molecule has been approved in recent years. Indeed, the last time we have seen the birth of only drugs "targeted therapy", which, as we know, are monoclonal antibodies. They are able to modify or block, starting from membrane receptors, intracellular signals, signal transduction pathways, without producing a persistent positive reaction towards neoplasia. In this situation came to rescue all natural medications with their active ingredients most suitable. Studies in Basic Searching the observations with traditional methods and the presentation of the first results of phase I and phase II are attracting a lot of attention. The discovery of the positive interaction use with chemotherapy and radiotherapy of substances such as polydatin, lactoferrin, boswellia serrata or curcumin and dozens of other natural substances has opened a new treatment scenario: the Integrative Oncology. The study of the possible synergistic interaction between chemotherapeutic drugs and natural substances has given rise to new researches. The Italian group of oncologists which belongs to the Association A.R.T.O.I. (Association of Integrative Oncology Therapies Research) had the strength and the courage to try these drugs integration. Observational studies have yielded first results of studies with Polydatin and AHCC. The benefit is visible through our treated cases.

The Integrative Oncology is the new reality for patients